Arecor Therapeutics PLC
LSE:AREC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Arecor Therapeutics PLC
LSE:AREC
|
UK |
|
Enterprise Products Partners LP
NYSE:EPD
|
US |
|
Oceania Healthcare Ltd
NZX:OCA
|
NZ |
|
HSC Technology Group Ltd
ASX:HSC
|
AU |
|
Titan Mining Corp
TSX:TI
|
CA |
|
MSP Recovery Inc
NASDAQ:LIFW
|
US |
|
Y
|
Yamuna Syndicate Ltd
BSE:540980
|
IN |
|
F.C.C. Co Ltd
TSE:7296
|
JP |
|
M
|
Micro Friend Inc
KOSDAQ:147760
|
KR |
|
D
|
Daewoo Electronic Components Co Ltd
KRX:009320
|
KR |
|
Smiths News PLC
LSE:SNWS
|
UK |
|
S4 Capital PLC
F:9S4
|
UK |
|
Nasdaq Inc
NASDAQ:NDAQ
|
US |
|
O
|
OM Holdings Ltd
ASX:OMH
|
SG |
|
T
|
Teton Advisors Inc
OTC:TETAA
|
US |
|
AMOS Group Ltd
SGX:49B
|
SG |
|
A
|
AREIT, Inc
XPHS:AREIT
|
PH |
|
D
|
Deluxe Family Co Ltd
SSE:600503
|
CN |
Wall Street
Price Targets
AREC Price Targets Summary
Arecor Therapeutics PLC
According to Wall Street analysts, the average 1-year price target for AREC is 281.01 GBX with a low forecast of 253.51 GBX and a high forecast of 315 GBX.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AREC's stock price target?
Price Target
281.01
GBX
According to Wall Street analysts, the average 1-year price target for AREC is 281.01 GBX with a low forecast of 253.51 GBX and a high forecast of 315 GBX.
What is Arecor Therapeutics PLC's Revenue forecast?
Projected CAGR
-44%
For the last 7 years the compound annual growth rate for Arecor Therapeutics PLC's revenue is 21%. The projected CAGR for the next 3 years is -44%.
